Biotek-snakken — September 2019
-
Nordic Nano er oppe med 25% på gode data
LYMRIT 37-01 (relapsed iNHL) - median duration of response of 13.6 months
for all responders and 32.0 months for complete responders versus 9.0 months and
20.7 months respectively reported last December at ASHArcher-1 - 100% ORR (3/3 complete response (CR)) in the first cohort of
patients in a phase 1b study of Betalutin + rituximab in relapsed/refractory
follicul -
Sukkeralf: Vil topline safety for ZW49 først komme næste år? Synes deres corporate pres. siger 2019, men
kan se du har skrevet januar 2020 i et af dine indlæg -
LP90..Jeg vender tilbage.
-
Øh - nu må du vist komme ud af middagssøvnen Pensio - du roder lidt idag
men hvem gør ikke det 
-
God morgen
-
Bliv en bedre biotekinvestor. http://www.proinvestor.com/index.php?p=debat_1&postid=76998
-
Har ikke undersøgt pipelinen i den grad. Synes bare den ser interessandt ud. https://thefly.com/landingPageNews.php?id=2955080&headline=fbio-fortress-biotech-initiated-with-a-buy-at-dawson-james
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind